Loading...
•
Dec 31, 2023
Pfizer Q4 2023 Earnings Report
Pfizer's Q4 2023 earnings were impacted by decline in Comirnaty and Paxlovid revenues, but non-COVID products showed strong growth.
Key Takeaways
Pfizer's Q4 2023 revenues were $14.2 billion, a 41% decrease compared to Q4 2022, primarily due to a decline in Comirnaty and Paxlovid revenues. Excluding these products, revenues grew 8%. The company reported a diluted loss per share of $(0.60) and adjusted diluted EPS of $0.10. Pfizer reaffirms its full-year 2024 guidance.
Q4 2023 revenues totaled $14.2 billion, a 41% decrease year-over-year.
Excluding Comirnaty and Paxlovid, Q4 2023 revenues grew 8% operationally.
Reported diluted loss per share was $(0.60), while adjusted diluted EPS was $0.10.
Pfizer reaffirms full-year 2024 revenue guidance of $58.5 to $61.5 billion and adjusted diluted EPS of $2.05 to $2.25.
Revenue by Segment
Forward Guidance
Pfizer expects full-year 2024 revenues to be in the range of $58.5 to $61.5 billion and Adjusted diluted EPS to be in the range of $2.05 to $2.25.
Positive Outlook
- Expected operational revenue growth of 8% to 10% compared to 2023 revenues, excluding Comirnaty and Paxlovid and including the impact of Seagen.
- Anticipated operating margin improvement from the company’s cost realignment activities.
Challenges Ahead
- An expected $0.40 dilutive impact related to the Seagen acquisition, which is predominantly driven by costs to finance the transaction.
- Assumes no share repurchases in 2024.
- Anticipated immaterial impact in fiscal-year 2024 of recent and expected generic and biosimilar competition for certain products that have recently lost patent protection or that are anticipated to lose patent protection.
- Exchange rates assumed are actual rates at mid-November 2023. Financial guidance reflects the anticipated unfavorable impact of approximately $0.3 billion on revenues and approximately $0.01 on Adjusted(3) diluted EPS as a result of changes in foreign exchange rates relative to the U.S. dollar compared to foreign exchange rates from 2023.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...